All Articles

Alterations in the serum lipid profile predict incident diabetes in obese individuals

Metabolic biomarkers predict subclinical cardiac remodeling in obese individuals

Should we shift from delaying diabetes to pursuing pre-diabetes remission for cardiovascular disease prevention?

Bilirubin ameliorates metabolic dysregulation by targeting the HSP90β/SREBPs signaling axis to improve insulin resistance and mitigate ectopic lipid deposition

The mediating role of systolic blood pressure in the association between estimated glucose disposal rate and renal prognosis: a nationwide prospective cohort study

Exploring the regulatory impact of insulin on type I collagen synthesis in hepatic stellate cells through α5β1 integrin

Insulin increases type I collagen synthesis in hepatic stellate cells via α5β1 integrin

Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1

From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus

Sarcopenia in the setting of nonalcoholic fatty liver

Risk of cardio-nephro-metabolic disease from NAFLD to MAFLD: fact or fiction?